MetaCap

Stryker Corporation (SYK)

NYSE: SYKHealth CareMedical/Dental InstrumentsUSD

310.00-3.08 (-0.98%)

At close: Nov 20, 4:01 PM ET · Delayed 15 min

SYK stock chart

Technical analysis

Key statistics

All statistics
Market cap
$118.01B
Dividend yield
1.14% ($3.52)
Ex-dividend date
Sep 30, 2026
52-week range
267.00 – 389.33
Day range
308.82 – 320.97
Volume / Avg
2.38M / 2.93M
Beta
—

52-week range

$267.00$389.33

SYK stock today

Stryker (SYK) closed at $310.00 on Nov 20, down 0.98% (-$3.08), versus the S&P 500's 3.70% decline. Shares are 20.4% below their 52-week high of $389.33, set on Mar 2, 2026 and 16.1% above the 52-week low of $267.00, in the middle of the past year's range. SYK is down 11.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 15.8%.

At 33.0x trailing earnings, Stryker trades in line with the peer-group median of 36.6x. Its forward P/E of 19.0x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Stryker pays an annual dividend of $3.52 per share, a 1.14% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About Stryker

Company profile

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products.

Industry
Medical/Dental Instruments
CEO
Mr. Kevin A. Lobo
Headquarters
Portage, MI
Employees
56,000

Financial highlights

Full financials

In fiscal 2025, Stryker generated $25.12 billion in revenue, up 11.2% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $3.25 billion (+8.5% year over year), for a net margin of 12.9% versus a median of 12.8% in the prior 5 years. Gross margin was 64.0% (up from 63.9%) and operating margin 19.5%.

Stryker annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$25.12B$22.59B$20.50B$18.45B$17.11B
Growth+11.16%+10.23%+11.11%+7.84%+19.21%
Net income$3.25B$2.99B$3.17B$2.36B$1.99B
EPS (diluted)$8.40$7.76$8.25$6.17$5.21

Analyst forecast

Forecast

Consensus (30 analysts)

buy

Avg. price target

$339.37+9.47%

  • Strong buy 8
  • Buy 14
  • Hold 8
  • Sell 0
  • Strong sell 0

Target range

Low $275.00High $410.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Oct 29, 2026
EPS actual vs est.
$3.19 vs $3.56
Surprise
-10.39%

Dividends

Dividend history
Annual dividend
$3.52
Last payment
$0.88
Ex-dividend date
Sep 30, 2026

SYK news

All SYK news

Stryker peers

Health Care sector
SYK peer companies
CompanyPrice% ChgMarket capCompare
MMM3M Company177.99-0.27%$91.97Bvs SYK
BSXBoston Scientific Corporation41.98-2.35%$60.85Bvs SYK
BDXBecton Dickinson and Company212.78+0.05%$57.96Bvs SYK
MDLNMedline Inc. Class A37.04-2.11%$48.75Bvs SYK
RMDResMed Inc.235.63-0.53%$33.14Bvs SYK
DXCMDexCom Inc.79.32-1.08%$29.58Bvs SYK
WSTWest Pharmaceutical Services Inc.390.30-1.61%$27.19Bvs SYK
SOLVSolventum Corporation84.50-1.52%$14.36Bvs SYK

Indexes, lists and sector

Stryker stock FAQ

What is Stryker's stock price today?

SYK last traded at $310.00 as of Nov 20, 4:01 PM EST, down 0.98% on the day. Prices are delayed at least 15 minutes.

Does Stryker pay a dividend?

Yes. Stryker pays $3.52 per share annually, a 1.14% yield. The most recent dividend of $0.88 had an ex-dividend date of Sep 30, 2026.

What is SYK's P/E ratio?

SYK trades at a trailing P/E ratio of 33.01 and a forward P/E of 19.03, compared with a median of 36.6 for its closest peers.

Is Stryker in the S&P 500?

Yes. Stryker (SYK) is a constituent of the S&P 500 index.

Who is Stryker's CEO?

Mr. Kevin A. Lobo is the chief executive officer of Stryker Corporation, which has about 56,000 employees.

Has SYK ever split its stock?

Yes. The most recent SYK stock split was a 2-for-1 split on May 17, 2004, one of 9 splits on record.

What is the SYK 52-week high?

The 52-week high for SYK is $389.33 and the 52-week low is $267.00. The stock is currently 20.4% below its high.

Compare SYK